Global Neurology Academy

Enhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
Enhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
Global Neurology Academy
Enhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
- Mark Gudesblatt, MD
Harnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
Harnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
NeuroFrontiers
Harnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
- Kelly Sloane, MD
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
NeuroFrontiers
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
Global Neurology Academy
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
- Marisa McGinley, DO
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
Global Neurology Academy
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
- Charles Turck, PharmD, BCPS, BCCCP
- Yinan Zhang, MD
- Sarah A. Morrow, MD, MS, FRCPC, FAAN
Understanding Schizophrenia: Early Intervention and Prevention Strategies
Understanding Schizophrenia: Early Intervention and Prevention Strategies
Global Neurology Academy
Understanding Schizophrenia: Early Intervention and Prevention Strategies
- Joseph F. Goldberg, MD
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
NeuroFrontiers
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
- Michael G. Dwyer, PhD
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
NeuroFrontiers
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
- Michael G. Dwyer, PhD

Medical News

Medical News
Open-World Video Games Found to Boost Mental Well-Being in Postgraduate Students
medicalxpress.com
01/08/2025
Read more
Medical News
Innovative Haptic Belt Shows Promise for Improving Mobility in People With Vision Loss
sciencedaily.com
01/08/2025
Read more
Medical News
Socioeconomic Factors Tied to Brain Lesion Severity in Pediatric MS
medicalxpress.com
01/08/2025
Read more
Medical News
Smartphone App Reduces Opioid Use and Enhances Treatment Retention, Study Finds
news.uthscsa.edu
01/07/2025
Read more

See more news

CME/CE

Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
MinuteCE®
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
1.25 program credits
- James R. Bateman, MD, MPH
- B. Joy Snider, MD, PhD
- Charles P. Vega, MD
1.25 program credits
MinuteCE®
Clinical Conundrums in ARIA: Navigating Case Scenarios in Your Own Practice Setting
1.25 credits 11 episodes
- James R. Bateman, MD, MPH
- Jerome A. Barakos, MD
- Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
- B. Joy Snider, MD, PhD
- Charles P. Vega, MD
1.25 credits 11 episodes
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
MinuteCE®
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
1.25 program credits
- James R. Bateman, MD, MPH
- Charles P. Vega, MD
- B. Joy Snider, MD, PhD
1.25 program credits
Clinical Conundrums in ARIA: How to Manage Severe ARIA
Clinical Conundrums in ARIA: How to Manage Severe ARIA
MinuteCE®
Clinical Conundrums in ARIA: How to Manage Severe ARIA
1.25 program credits
- James R. Bateman, MD, MPH
- Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
- B. Joy Snider, MD, PhD
1.25 program credits

Clinical Practice

Inflammatory Gateways: Exploring the Role of the Choroid Plexus in Post-TBI Care
Inflammatory Gateways: Exploring the Role of the Choroid Plexus in Post-TBI Care
NeuroFrontiers
Inflammatory Gateways: Exploring the Role of the Choroid Plexus in Post-TBI Care
- Prajwal Ciryam, MD, PhD
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
Global Neurology Academy
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
- Charles Turck, PharmD, BCPS, BCCCP
- Kimberly DiMauro, DO
- Carol Swetlik, MD
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
Global Neurology Academy
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
- Joseph F. Goldberg, MD
Studying Cortical Lesions in MS: Future Research Directions
Studying Cortical Lesions in MS: Future Research Directions
NeuroFrontiers
Studying Cortical Lesions in MS: Future Research Directions
- Michael G. Dwyer, PhD

Programs

Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
NeuroFrontiers
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
- Andrew J. Solomon, MD
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
Global Neurology Academy
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
- Karissa Gable, MD
Optimizing Neuromuscular Disease Care: How to Assess and Address Respiratory Risks
Optimizing Neuromuscular Disease Care: How to Assess and Address Respiratory Risks
NeuroFrontiers
Optimizing Neuromuscular Disease Care: How to Assess and Address Respiratory Risks
- Charles Turck, PharmD, BCPS, BCCCP
- Jason Ackrivo, MD, MSCE
- Bethany Lussier, MD
Optimizing TK2d Care Through a Multidisciplinary Approach
Optimizing TK2d Care Through a Multidisciplinary Approach
NeuroFrontiers
Optimizing TK2d Care Through a Multidisciplinary Approach
- Charles Turck, PharmD, BCPS, BCCCP
- Kaitlin Batley, MD
- Esra Caylan, MD